Agios Pharmaceuticals (AGIO) issued a press release on July 30, 2026, announcing its results for the quarter ended June 30, 2026, along with other business highlights. The company furnished the release as Exhibit 99.1 to this Form 8-K under Items 2.02 and 9.01. Because the material is “furnished” rather than “filed,” it is not subject to Section 18 liability under the Exchange Act. No specific financial figures appear in the excerpt itself.
View Full Filing (SEC EDGAR)